Clinical Trials Logo

Uterine Cervical Dysplasia clinical trials

View clinical trials related to Uterine Cervical Dysplasia.

Filter by:

NCT ID: NCT02697175 Completed - Clinical trials for Uterine Cervical Dysplasia

Video Colposcopy in Women With Dysplasia

Start date: August 2016
Phase: N/A
Study type: Interventional

To assess the effect of live video-colposcopy on women´s anxiety.

NCT ID: NCT02693379 Completed - Cervical Precancer Clinical Trials

Cervical Cancer Screening in Madagascar Using Smartphone Photos and Mobile Telemedicine

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether smartphone photos may assist health-care worker (on-site) and to evaluate the diagnostic reliability and accuracy of cervical examination with smartphone photos of VIA (D-VIA), on-site and off-site, compared with conventional VIA, for human papillomavirus (HPV) positive women.

NCT ID: NCT02631863 Completed - Clinical trials for Cervical Intraepithelial Neoplasia

Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)

Start date: March 22, 2016
Phase: Phase 2
Study type: Interventional

This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).

NCT ID: NCT02515162 Completed - Clinical trials for Uterine Cervical Dysplasia

Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization

Start date: July 2015
Phase: N/A
Study type: Interventional

In a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, two electrosurgical excision methods, Fischer Cone Biopsy Excison vs. Loop Excision Procedure, will be compared. The primary outcome of the study is dysplasia-free resection margin rate, secondary outcomes are intraoperative blood loss, time to complete hemostasis, intervention time, postoperative pain, intra- and postoperative complications, the resected cone volume and users satisfaction.

NCT ID: NCT02500966 Completed - Stenosis Cervix Clinical Trials

How to Avoid Cervical Stenosis After LEEP in High Grade Cervical Dysplasia?

DUDA
Start date: August 2015
Phase: N/A
Study type: Interventional

Cervical stenosis may occur in up to 19% after conization. It is a cause of infertility and amenorrhea. This study will test a new device named DUDA Device ("Dispositivo Uterino para dilatar canal endocervical") placed just after the conization, in order to evaluate the safety, efficacy and quality of life.

NCT ID: NCT02486471 Completed - Clinical trials for Uterine Cervical Dysplasia

Hemostatic Procedure After Biopsy of the Cervix

Start date: July 2015
Phase: N/A
Study type: Interventional

Cytological abnormalities of the Cervix uteri need to be clarified by colposcopy biopsy. To avoid bleeding after biopsy, monsel´s paste is a common used Agent. In a randomized clinical Trial the use of monsel´s paste after biopsy will be compared to no Intervention. The Primary outcome of the study is blood loss, secondary outcomes are pain, satisfaction of the patient and influence of Independent factors such as Age and Body mass index.

NCT ID: NCT02481414 Completed - Clinical trials for Cervical Intraepithelial Neoplasia

A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Start date: November 30, 2015
Phase: Phase 2
Study type: Interventional

This is a Phase II study to evaluate the efficacy and safety of a human papilloma virus (HPV) therapeutic vaccine called PepCan (HPV 16 E6 peptides combined with Candida skin testing reagent called Candin®) in adult females over a 12 month time period. As the results from the Phase I trial demonstrated some efficacy against non-16 HPV types, Candin alone will also be tested. Therefore, there will be two treatment arms: (1) PepCan and (2) Candin. Subjects found to be eligible for vaccination will be randomized in a double-blinded fashion at a 1:1 ratio. Each participant will be receiving injections four times with three weeks between injections. Clinical and virological responses will be assessed at 6 and 12 months. Safety will be assessed from the time of enrollment to 12 Month Visit. Immunological assessments will be made at 4 time points (prevaccination, after 2 injections, 6 month after 4 injections and 12 months after 4 vaccinations).

NCT ID: NCT02476500 Completed - Cervical Dysplasia Clinical Trials

Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model

LLETZ-1
Start date: May 2015
Phase: N/A
Study type: Interventional

In a prospective case-control study, 140 medical students (,novices') and 10 Senior gynecologists (,experts') will perform a Large Loop Excision of the Transformation Zone (LLETZ) on a Training model afte having undergone a Video Training session. Their LLETZ-Performance will be assessed using an Objective Structured Assessment of Technical Skills (OSATS) protocol designed for judging the surgical proficiency when performing a LLETZ. Using metrical and non-metrical data points, construct validity of the LLETZ training model to distinguish between experts and novices will be assessed. Secondary endpoints are differences in OSATS scores within the group of novices based on gender and handyness, as well as satisfaction of the novices with the learning experience.

NCT ID: NCT02420665 Completed - Cervical Cancer Clinical Trials

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

Start date: September 23, 2015
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical research study is to compare a type of imaging called high-resolution microendoscopy (HRME) for detecting abnormal tissue in the cervix to the standard of care, which is visual inspection with acetic acid (VIA) with a colposcopy procedure. Researchers also want to learn if HRME images can show the difference between cancerous tissue and normal cervical tissue.

NCT ID: NCT02378324 Completed - Cervical Dysplasia Clinical Trials

Effect of Fee on Attendance in Cervical Cancer Screening

Start date: January 2013
Phase: N/A
Study type: Interventional

Several reasons can explain non-attendance in cervical cancer screening. In low resource settings the attendance is even lower. The effect of fee as contributing reason of non attendance has not been studied before why the investigators decided to study this in a low resource setting as a randomised trial.